Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -173,899 | -113,902 | -72,113 | -128,081 | -79,751 |
| Depreciation Amortization | 21,963 | 14,133 | 6,941 | 26,178 | 19,352 |
| Accounts receivable | 5,879 | -9,702 | 20,786 | -29,589 | -2,681 |
| Other Working Capital | -9,830 | -25,100 | -10,507 | 14,209 | 18,537 |
| Other Operating Activity | 67,454 | 61,640 | 12,484 | 89,642 | 32,045 |
| Operating Cash Flow | $-88,433 | $-72,931 | $-42,409 | $-27,641 | $-12,498 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -124,886 | -171,837 | -147,633 | 21,809 | 37,267 |
| PPE Investments | -9,104 | -4,851 | -2,865 | -7,097 | -2,489 |
| Net Acquisitions | N/A | N/A | N/A | -48,892 | -48,892 |
| Purchase Of Investment | -4,000 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -20,250 | -11,981 | N/A | -8,433 | -3,903 |
| Other Investing Activity | -20,250 | -11,981 | 0 | -8,433 | -3,903 |
| Investing Cash Flow | $-158,240 | $-188,669 | $-150,498 | $-42,613 | $-18,017 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 279,571 | N/A | N/A | N/A | N/A |
| Debt Repayment | -6,667 | -1,667 | 0 | N/A | N/A |
| Common Stock Issued | 338,021 | 230,238 | 225,722 | 131,571 | 127,845 |
| Financing Cash Flow | $610,925 | $228,571 | $225,722 | $131,571 | $127,845 |
| Exchange Rate Effect | -2,673 | -375 | -1,169 | -3,611 | -2,209 |
| Beginning Cash Position | 169,498 | 169,498 | 169,498 | 111,792 | 111,792 |
| End Cash Position | 531,077 | 136,094 | 201,144 | 169,498 | 206,913 |
| Net Cash Flow | $361,579 | $-33,404 | $31,646 | $57,706 | $95,121 |
| Free Cash Flow | |||||
| Operating Cash Flow | -88,433 | -72,931 | -42,409 | -27,641 | -12,498 |
| Capital Expenditure | -9,104 | -4,851 | -2,865 | -7,097 | -2,489 |
| Free Cash Flow | -97,537 | -77,782 | -45,274 | -34,738 | -14,987 |